Connor, Clark & Lunn Investment Management (CC&L)
CMPX icon

Connor, Clark & Lunn Investment Management (CC&L)’s Compass Therapeutics CMPX Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio CMPX Stock Details CMPX Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$1.03M Buy
2025
Q1 		– Sell
2024
Q4 		$227K Sell
2024
Q3 		$427K Buy
2024
Q2 		$232K Sell
2024
Q1 		$477K Buy
2023
Q4 		$332K Buy
2023
Q3 		$262K Buy
2023
Q2 		$366K Buy
2023
Q1 		$73.7K Buy